783 related articles for article (PubMed ID: 9565447)
1. Hepatorenal syndrome.
Bataller R; Arroyo V; Ginès P; Sort P
Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
[TBL] [Abstract][Full Text] [Related]
2. Hepatorenal syndrome.
Bataller R; Ginès P; Guevara M; Arroyo V
Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
[TBL] [Abstract][Full Text] [Related]
3. Hepatorenal syndrome.
Biswas KD; Jain AK
Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of hepatorenal syndrome.
Ginès P
Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348
[TBL] [Abstract][Full Text] [Related]
5. Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
Cárdenas A
Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508
[TBL] [Abstract][Full Text] [Related]
6. Hepatorenal syndrome.
Bataller R; Ginès P; Arroyo V; Rodés J
Clin Liver Dis; 2000 May; 4(2):487-507. PubMed ID: 11232202
[TBL] [Abstract][Full Text] [Related]
7. Hepatorenal syndrome.
Kramer L; Hörl WH
Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
[TBL] [Abstract][Full Text] [Related]
8. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
9. Hepatorenal syndrome.
Cárdenas A; Arroyo V
Ann Hepatol; 2003; 2(1):23-9. PubMed ID: 15094702
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and treatment of hepatorenal syndrome.
Wong F; Blendis L
Gastroenterologist; 1998 Jun; 6(2):122-35. PubMed ID: 9660529
[TBL] [Abstract][Full Text] [Related]
11. Hepatorenal syndrome.
Guevara M; Rodés J
Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
[TBL] [Abstract][Full Text] [Related]
12. Review article: pharmacological treatment of hepatorenal syndrome.
Ginès P; Torre A; Terra C; Guevara M
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():57-62; discussion 63-4. PubMed ID: 15335404
[TBL] [Abstract][Full Text] [Related]
13. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
[No Abstract] [Full Text] [Related]
14. The management of hepatorenal syndrome.
Carl DE; Sanyal A
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
[TBL] [Abstract][Full Text] [Related]
15. New treatments of hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
Semin Liver Dis; 2006 Aug; 26(3):254-64. PubMed ID: 16850375
[TBL] [Abstract][Full Text] [Related]
16. Therapy insight: Management of hepatorenal syndrome.
Cárdenas A; Ginès P
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in hepatorenal syndrome.
Arroyo V; Torre A; Guevara M
Trop Gastroenterol; 2005; 26(1):13-20. PubMed ID: 15974232
[TBL] [Abstract][Full Text] [Related]
18. [Hepatorenal syndrome].
Mijac D; Kezić A; Stojimirović B
Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
[TBL] [Abstract][Full Text] [Related]
19. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
[TBL] [Abstract][Full Text] [Related]
20. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]